Literature DB >> 22766379

Comparison of microCT and an inverse finite element approach for biomechanical analysis: results in a mesenchymal stem cell therapeutic system for fracture healing.

Jared A Weis1, Froilán Granero-Moltó, Timothy J Myers, Lara Longobardi, Anna Spagnoli, Michael I Miga.   

Abstract

An important concern in the study of fracture healing is the ability to assess mechanical integrity in response to candidate therapeutics in small-animal systems. In recent reports, it has been proposed that microCT image-derived densitometric parameters could be used as a surrogate for mechanical property assessment. Recently, we have proposed an inverse methodology that iteratively reconstructs the modulus of elasticity of the lumped soft callus/hard callus region by integrating both intrinsic mechanical property (from biomechanical testing) and geometrical information (from microCT) within an inverse finite element analysis (FEA) to define a callus quality measure. In this paper, data from a therapeutic system involving mesenchymal stem cells is analyzed within the context of comparing traditional microCT densitometric and mechanical property metrics. In addition, a novel multi-parameter regression microCT parameter is analyzed as well as our inverse FEA metric. The results demonstrate that the inverse FEA approach was the only metric to successfully detect both longitudinal and therapeutic responses. While the most promising microCT-based metrics were adequate at early healing states, they failed to track late-stage mechanical integrity. In addition, our analysis added insight to the role of MSCs by demonstrating accelerated healing and was the only metric to demonstrate therapeutic benefits at late-stage healing. In conclusion, the work presented here indicates that microCT densitometric parameters are an incomplete surrogate for mechanical integrity. Additionally, our inverse FEA approach is shown to be very sensitive and may provide a first-step towards normalizing the often challenging process of assessing mechanical integrity of healing fractures.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22766379      PMCID: PMC3782612          DOI: 10.1016/j.jbiomech.2012.05.033

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  17 in total

1.  Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone.

Authors:  Xiaowei S Liu; Paul Sajda; Punam K Saha; Felix W Wehrli; X Edward Guo
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

Review 2.  Mesenchymal stem cells at the intersection of cell and gene therapy.

Authors:  Timothy J Myers; Froilan Granero-Molto; Lara Longobardi; Tieshi Li; Yun Yan; Anna Spagnoli
Journal:  Expert Opin Biol Ther       Date:  2010-12       Impact factor: 4.388

3.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

4.  Prediction of fracture callus mechanical properties using micro-CT images and voxel-based finite element analysis.

Authors:  Sandra J Shefelbine; Ulrich Simon; Lutz Claes; Andreas Gold; Yankel Gabet; Itai Bab; Ralph Müller; Peter Augat
Journal:  Bone       Date:  2005-03       Impact factor: 4.398

5.  Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.

Authors:  M Oyama; A Tatlock; S Fukuta; K Kavalkovich; K Nishimura; B Johnstone; P D Robbins; C H Evans; C Niyibizi
Journal:  Gene Ther       Date:  1999-03       Impact factor: 5.250

6.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

7.  Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; P L Gordon; W W Koo; L A Fitzpatrick; M D Neel; M E McCarville; P J Orchard; R E Pyeritz; M K Brenner
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

8.  The cell and molecular biology of fracture healing.

Authors:  T A Einhorn
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

9.  Concepts of fracture union, delayed union, and nonunion.

Authors:  D Marsh
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

Review 10.  Mesenchymal stem cells in osteobiology and applied bone regeneration.

Authors:  S P Bruder; N Jaiswal; N S Ricalton; J D Mosca; K H Kraus; S Kadiyala
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

View more
  3 in total

1.  Fracture healing in mice lacking Pten in osteoblasts: a micro-computed tomography image-based analysis of the mechanical properties of the femur.

Authors:  Caitlyn J Collins; Juan F Vivanco; Scott A Sokn; Bart O Williams; Travis A Burgers; Heidi-Lynn Ploeg
Journal:  J Biomech       Date:  2014-11-28       Impact factor: 2.712

2.  The association between mineralised tissue formation and the mechanical local in vivo environment: Time-lapsed quantification of a mouse defect healing model.

Authors:  Duncan C Tourolle Né Betts; Esther Wehrle; Graeme R Paul; Gisela A Kuhn; Patrik Christen; Sandra Hofmann; Ralph Müller
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

3.  Finite element analysis of a bone healing model: 1-year follow-up after internal fixation surgery for femoral fracture.

Authors:  Zhou Jiang-Jun; Zhao Min; Yan Ya-Bo; Lei Wei; Lv Ren-Fa; Zhu Zhi-Yu; Chen Rong-Jian; Yu Wei-Tao; Du Cheng-Fei
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.